SEC Form 4 · accession 0001140361-16-087794
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Nov 21, 2016
Accepted (ET)
Nov 23, 2016 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 21, 2016 | M | 69,744 | $26.49 | A | 240,426 | D | |
| Common StockF1,F3,F2 | Nov 21, 2016 | S | 69,744 | $87.5556 | D | 170,682 | D | |
| Common StockF1,F2 | Nov 22, 2016 | M | 69,743 | $26.49 | A | 240,425 | D | |
| Common StockF1,F4,F2 | Nov 22, 2016 | S | 69,743 | $85.6934 | D | 170,682 | D | |
| Common StockF2 | holding | — | — | — | 182,801 | I | Shares held by Jean-Jacques Bienaime Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F1,F5 | $26.49 | Nov 21, 2016 | M | 69,744 | D | Nov 12, 2011 | May 11, 2021 | Common Stock | 69,744 | 210,256 | D |
| Stock Option (right to buy Common Stock)F1,F5 | $26.49 | Nov 22, 2016 | M | 69,743 | D | Nov 12, 2011 | May 11, 2021 | Common Stock | 69,743 | 140,513 | D |
Explanation of responses
- F1Trade made pursuant to a 10b5-1 plan executed on June 9, 2016. Mr. Bienaime's former spouse will receive the net proceeds from the shares sold in this transaction in connection with cash payments owed to her pursuant to a marital separation agreement between her and Mr. Bienaime.
- F2The amount of securities beneficially owned has been updated from the reporting person's prior Form 4 to reflect (a) changes in the form of ownership due to transfers made by the reporting person between accounts held directly and indirectly in the name of the Bienaime Family Trust and the Jean-Jacques Bienaime Family Trust and (b) an additional 4,357 shares beneficially owned by the reporting person pursuant to a reconciliation of the Company's records following the completion of the transfer of shares in connection with the reporting person's marital separation agreement.
- F3The price in column 4 is the weighted average price. The price actually received ranged from $86.74 to $89.59. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- F4The price in column 4 is the weighted average price. The price actually received ranged from $84.45 to $88.16. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- F5Reflects the number of stock options outstanding after the transaction from this specific stock option grant.